United States
US 12,697,394 B2
Muscle targeting complexes and formulations for treating myotonic dystrophy
US 12,697,394 B2 is a granted patent from the United States Patent and Trademark Office (USPTO), dated 2026-08-04. Applicant: Dyne Therapeutics, Inc. Its PDF downloads from this page without an account, up to 5 a day.
- Applicant
- Dyne Therapeutics, Inc.
- Inventors
- Scott Hilderbrand; Timothy Weeden; John Najim; Stefano Zanotti; Romesh R. Subramanian; Mohammed T. Qatanani; Cody A. Desjardins; Kim Tang; Brendan Quinn
- Publication date
- 2026-08-04
- Filing date
- 2025-08-21
- Document type
- B2 Granted patent
- Also written as
- US 12,697,394 B2 · US12697394 · 12697394
Abstract
Aspects of the disclosure relate to complexes and other aspects relate to formulations (e.g., aqueous, lyophilized forms) comprising such complexes comprising an oligonucleotide (e.g., useful for targeting DMPK) covalently linked to an antibody (e.g., anti-TfR1 antibody).
The opening of the abstract. The full text is in the PDF.
No account needed: 5 free downloads a day (5 left today). Batch downloads and Office Action citations need a free account.
Patent office website: United States Patent and Trademark Office (USPTO)
Look up another patent
Need many patents at once?
Paste a whole list of numbers. DownloadPatent finds the right version of each and packs the PDFs into one ZIP.
Sign up free